.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Find suppliers and generic API sources
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Novartis
Medtronic
UBS
Moodys
AstraZeneca
Boehringer Ingelheim
Cerilliant
Julphar
Baxter
Merck

Generated: June 28, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 075551

« Back to Dashboard
NDA 075551 describes LOVASTATIN, which is a drug marketed by Sandoz, Sun Pharm Inds, Actavis Elizabeth, Mylan, Apotex Inc, Teva, Carlsbad, and Lupin, and is included in ten NDAs. It is available from thirty-eight suppliers. Additional details are available on the LOVASTATIN profile page.

The generic ingredient in LOVASTATIN is lovastatin. There are thirty-three drug master file entries for this compound. Forty suppliers are listed for this compound. Additional details are available on the lovastatin profile page.

Summary for NDA: 075551

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 075551

Suppliers and Packaging for NDA: 075551

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
LOVASTATIN
lovastatin
TABLET;ORAL 075551 ANDA Teva Pharmaceuticals USA, Inc. 0093-0576 0093-0576-06 60 TABLET in 1 BOTTLE (0093-0576-06)
LOVASTATIN
lovastatin
TABLET;ORAL 075551 ANDA Teva Pharmaceuticals USA, Inc. 0093-0576 0093-0576-10 1000 TABLET in 1 BOTTLE (0093-0576-10)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength40MG
Approval Date:Dec 17, 2001TE:ABRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength20MG
Approval Date:Dec 17, 2001TE:ABRLD:No

Summary for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength10MG
Approval Date:Dec 17, 2001TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Covington
Cipla
Accenture
Fuji
Federal Trade Commission
McKinsey
US Army
Cerilliant
Merck
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot